Related Experiment Video
Updated: Jan 3, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
Effect of Antimalarial Drugs on the Immune Response to Intramuscular Rabies Vaccination Using a Postexposure
Timothy P Endy1,2, Paul B Keiser3, Don Cibula4
1Institute for Global Health and Translational Sciences, State University of New York Upstate Medical University, Syracuse, New York, USA.
Chloroquine reduced rabies antibody response, but accepted levels were achieved with chloroquine, Malarone, and doxycycline. Malarone and doxycycline did not impact rabies vaccine antibody titers.
Area of Science:
- Immunology
- Vaccinology
- Tropical Medicine
Background:
- Antimalarial drugs can affect immune responses to vaccines.
- Current guidelines suggest additional rabies vaccine doses for those on antimalarials.
Purpose of the Study:
- To evaluate the impact of chloroquine, Malarone, and doxycycline on antibody response to rabies vaccination.
- To compare immune responses across different antimalarial treatment groups.
Main Methods:
- A randomized, open-label study involved 103 unvaccinated adults.
- Participants received antimalarials before and during rabies vaccination.
- Antibody titers were measured post-vaccination.
Main Results:
- All subjects achieved protective rabies antibody titers (≥0.5 IU/mL).
- Chloroquine showed a reduction in rabies antibody geometric mean titer compared to controls (2.3 vs 6.87 IU/mL).
- Malarone and doxycycline did not significantly alter rabies antibody titers.
Conclusions:
- Malarone and doxycycline do not reduce rabies antibody response.
- Chloroquine significantly reduces rabies antibody response, though protective levels are still achieved.
- Accepted rabies antibody levels were achieved with all tested antimalarials.
More Related Videos
07:54Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test
Published on: January 19, 2024
11:28Analysis of Iophenoxic Acid Analogues in Small Indian Mongoose Herpestes Auropunctatus Sera for Use as an Oral Rabies Vaccination Biological Marker
Published on: May 31, 2019